215 related articles for article (PubMed ID: 23715031)
1. Recent mouse and rat methods for the study of experimental oral candidiasis.
Costa AC; Pereira CA; Junqueira JC; Jorge AO
Virulence; 2013 Jul; 4(5):391-9. PubMed ID: 23715031
[TBL] [Abstract][Full Text] [Related]
2. [Virulence of Candida dubliniensis in comparison with Candida albicans using an experimental model of mouse oral candiddiasis].
Yoshioka H; Ito-Kuwa S; Nakamura K; Mataga I
Med Mycol J; 2012; 53(2):135-45. PubMed ID: 22728597
[TBL] [Abstract][Full Text] [Related]
3. Models hosts for the study of oral candidiasis.
Junqueira JC
Adv Exp Med Biol; 2012; 710():95-105. PubMed ID: 22127889
[TBL] [Abstract][Full Text] [Related]
4. [Experimental oral candidiasis in healthy and immunocompromised BALB/c mice].
Karaman M; Kiray M; Bayrakal V; Bağrıyanık HA; Yılmaz O; Bahar IH
Mikrobiyol Bul; 2011 Apr; 45(2):336-43. PubMed ID: 21644077
[TBL] [Abstract][Full Text] [Related]
5. Virulence of oral Candida isolated from HIV-positive women with oral candidiasis and asymptomatic carriers.
Owotade FJ; Patel M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Oct; 118(4):455-60. PubMed ID: 25201119
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal colonisation and systemic spread of Candida albicans in mice treated with antibiotics and prednisolone.
Kobayashi-Sakamoto M; Tamai R; Isogai E; Kiyoura Y
Microb Pathog; 2018 Apr; 117():191-199. PubMed ID: 29477742
[TBL] [Abstract][Full Text] [Related]
7. The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosa.
Samaranayake YH; Wu PC; Samaranayake LP; Ho PL
J Med Microbiol; 1998 Dec; 47(12):1047-57. PubMed ID: 9856640
[TBL] [Abstract][Full Text] [Related]
8. Experimental oral candidiasis in animal models.
Samaranayake YH; Samaranayake LP
Clin Microbiol Rev; 2001 Apr; 14(2):398-429. PubMed ID: 11292645
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis, microbiological and clinical aspects of oral candidiasis (candidosis).
Hermann P; Berek Z; Nagy G; Kamotsay K; Rozgonyi F
Acta Microbiol Immunol Hung; 2001; 48(3-4):479-95. PubMed ID: 11791346
[TBL] [Abstract][Full Text] [Related]
10. Powder diet exacerbates oropharyngeal candidiasis in a mouse model.
Vazquez-Munoz R; Thompson A; Sobue T; Dongari-Bagtzoglou A
Appl Environ Microbiol; 2024 Mar; 90(3):e0171323. PubMed ID: 38319097
[TBL] [Abstract][Full Text] [Related]
11. Combination of Estrogen and Immunosuppressive Agents to Establish a Mouse Model of Candidiasis with Concurrent Oral and Vaginal Mucosal Infection.
Wang L; Wang C; Mei H; Shen Y; Lv G; Zeng R; Zhan P; Li D; Liu W
Mycopathologia; 2016 Feb; 181(1-2):29-39. PubMed ID: 26404163
[TBL] [Abstract][Full Text] [Related]
12. Mouse model of oropharyngeal candidiasis.
Solis NV; Filler SG
Nat Protoc; 2012 Mar; 7(4):637-42. PubMed ID: 22402633
[TBL] [Abstract][Full Text] [Related]
13. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
[TBL] [Abstract][Full Text] [Related]
14. Iron Chelator Deferasirox Reduces
Puri S; Kumar R; Rojas IG; Salvatori O; Edgerton M
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718249
[No Abstract] [Full Text] [Related]
15. Oral mucosal lesions caused by Candida albicans.
de Waal H
SADJ; 2003 Mar; 58(2):76. PubMed ID: 12800271
[No Abstract] [Full Text] [Related]
16. Genotyping of Candida albicans and Candida dubliniensis by 25S rDNA analysis shows association with virulence attributes in oral candidiasis.
Tantivitayakul P; Panpradit N; Maudcheingka T; Klaophimai A; Lapirattanakul J
Arch Oral Biol; 2019 Jan; 97():18-24. PubMed ID: 30321765
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of human saliva on experimental murine oral candidiasis.
Kamagata-Kiyoura Y; Abe S; Yamaguchi H; Nitta T
J Infect Chemother; 2004 Aug; 10(4):253-5. PubMed ID: 15365870
[TBL] [Abstract][Full Text] [Related]
18. Effect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model.
Ishijima SA; Hayama K; Burton JP; Reid G; Okada M; Matsushita Y; Abe S
Appl Environ Microbiol; 2012 Apr; 78(7):2190-9. PubMed ID: 22267663
[TBL] [Abstract][Full Text] [Related]
19. Use of photodynamic therapy and chitosan for inactivacion of Candida albicans in a murine model.
Fabio CA; Yolanda MB; Carmen GM; Francisco C; Antonio Julián B; Leonor PL; Jesús S
J Oral Pathol Med; 2016 Sep; 45(8):627-33. PubMed ID: 26991463
[TBL] [Abstract][Full Text] [Related]
20. N-acetylglucosamine increases symptoms and fungal burden in a murine model of oral candidiasis.
Ishijima SA; Hayama K; Takahashi M; Holmes AR; Cannon RD; Abe S
Med Mycol; 2012 Apr; 50(3):252-8. PubMed ID: 21859389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
